PM
XGN icon

Penbrook Management’s Exagen XGN Stock Holding History

Penbrook Management’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,330
Closed -$40K – 103
2026
Q1 		$40K Sell
13,330
-100
-0.7% -$387 0.03% 93
2025
Q4 		$81.7K Sell
13,430
-6,480
-33% -$59K 0.06% 95
2025
Q3 		$219K Hold
19,910
– – 0.15% 87
2025
Q2 		$139K Sell
19,910
-19,455
-49% -$118K 0.1% 92
2025
Q1 		$141K Sell
39,365
-5,229
-12% -$19.7K 0.11% 100
2024
Q4 		$183K Sell
44,594
-18,361
-29% -$66.2K 0.12% 100
2024
Q3 		$195K Sell
62,955
-6,500
-9% -$16.8K 0.13% 96
2024
Q2 		$126K Sell
69,455
-7,255
-9% -$12.3K 0.08% 98
2024
Q1 		$122K Buy
76,710
+1,000
+1% +$1.94K 0.08% 101
2023
Q4 		$151K Buy
75,710
+2,300
+3% +$3.98K 0.1% 96
2023
Q3 		$178K Sell
73,410
-600
-0.8% -$1.52K 0.13% 91
2023
Q2 		$215K Hold
74,010
– – 0.16% 88
2023
Q1 		$180K Hold
74,010
– – 0.14% 89
2022
Q4 		$178K Sell
74,010
-12,990
-15% -$33.3K 0.15% 89
2022
Q3 		$236K Sell
87,000
-1,100
-1% -$6.14K 0.2% 85
2022
Q2 		$506K Sell
88,100
-500
-0.6% -$2.91K 0.4% 66
2022
Q1 		$711K Hold
88,600
– – 0.46% 62
2021
Q4 		$1.03M Buy
88,600
+850
+1% +$9.96K 0.62% 49
2021
Q3 		$1.19M Buy
+87,750
New +$1.17M 0.74% 47

Other funds holding XGN

WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Penbrook Management's XGN Position: Q2 2026 in Review

Penbrook Management sold out of Exagen (XGN) in Q2 2026, closing a stake of 13,330 shares — an estimated $40K sold.

Penbrook Management first reported a position in XGN in Q3 2021 and held it in 19 quarters. The position peaked at $1.19M in Q3 2021. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

  • Penbrook Management reported no remaining Exagen position as of Q2 2026 after selling out during the quarter.
  • Penbrook Management sold 13,330 Exagen shares in Q2 2026, an estimated $40K.
  • Penbrook Management first reported a position in Exagen in Q3 2021 and held it in 19 quarters.
  • Penbrook Management's Exagen position peaked at $1.19M in Q3 2021.
  • 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on Penbrook Management's 13F filing for Q2 2026, filed 23 Jul 2026.